U.S. JPML Determined that Suboxone tooth decay lawsuits filed throughout the federal court system will be centralized in the Northern District of Ohio for discovery and pretrial proceedings.
Use of buprenorphine, the active ingredient in Suboxone and other opioid addiction treatments, during the first trimester of pregnancy was associated with a lower risk of most congenital malformations than methadone.
Babies exposed to opioids before birth were 18% more likely to develop infections, and were also 35% more likely to be diagnosed with a skin condition.
Kentucky man used the film strips for more than a decade to treat opioid use disorder, before learning the side effects of Suboxone were ruining his teeth.
Researchers recommend doctors ask mothers about dietary supplement the are using, due to the risk of neonatal abstinence syndrome (NAS).
Pennsylvania woman used the opioid addiction treatment for nine years before Suboxone tooth decay warnings were finally placed on the drug label, leaving her with extensive dental injuries and tooth damage.
The FDA RADARS program was originally created by Purdue Pharma, which has often been blamed for its role in creating the opioid abuse and addiction crisis.
Maine woman indicates in a recently filed Suboxone dental erosion lawsuit that she had to undergo extensive dental work after using the opioid addiction drug, which left her with permanently damaged teeth.
New opioid addiction warnings are designed to help doctors and patients make better decisions about what to prescribe for pain management.
At least 15 Suboxone tooth decay lawsuits have already been filed in five different U.S. District Courts, with hundreds of additional claims under active investigation by lawyers nationwide.
